April 24, 2024, 11 a.m. | Ashlee Vance

Bloomberg Technology bloomberg.com

Transcripta Bio’s AI software analyzes rare diseases to see if existing pharmaceuticals can help.

ai software bio diseases drugs pharma pharmaceuticals rare diseases software startup test

Founding AI Engineer, Agents

@ Occam AI | New York

AI Engineer Intern, Agents

@ Occam AI | US

AI Research Scientist

@ Vara | Berlin, Germany and Remote

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Codec Avatars Research Engineer

@ Meta | Pittsburgh, PA